Brivaracetam for the treatment of epilepsy.

about

Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond Evaluation of brivaracetam: a new drug to treat epilepsy.Will Brivaracetam Help My Patient? Only Time Will Tell.A review of the pharmacology and clinical efficacy of brivaracetam.

P2860

Q28068507-108BF752-2749-465E-972A-DE698F1876F1 Q38652806-5029C05E-41CE-4510-9F13-4413C55733B5 Q42317849-0DF0A04E-4D95-48CD-82E7-A9EB92B162AB Q49700507-A37353A0-3F88-4C15-AA3C-A83BA6CCCA5D

P2860

Brivaracetam for the treatment of epilepsy.

Item

http://www.wikidata.org/entity/Q38694479

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Brivaracetam for the treatment of epilepsy.

@en

type

Item

label

Brivaracetam for the treatment of epilepsy.

@en

prefLabel

Brivaracetam for the treatment of epilepsy.

@en

P1476

Brivaracetam for the treatment of epilepsy.

@en

P2093

Ivan Rektor

http://www.w3.org/2001/XMLSchema#string

Ivana Tyrlikova

http://www.w3.org/2001/XMLSchema#string

Milan Brazdil

http://www.w3.org/2001/XMLSchema#string

Pavel Klein

http://www.w3.org/2001/XMLSchema#string

P2860

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

Brivaracetam: a rational drug discovery success story

Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma.

Early identification of refractory epilepsy

Pharmacokinetics and metabolism of 14C-brivaracetam, a novel SV2A ligand, in healthy subjects

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men

Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.

Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X).

Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model.

Patterns of treatment response in newly diagnosed epilepsy.

P304

283-295

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2016.1135129

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26760311

http://www.w3.org/2001/XMLSchema#string

P921

brivaracetam

Brivaracetam for the treatment of epilepsy.

about

P2860

P2860

Brivaracetam for the treatment of epilepsy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921